WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 January 2021 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

  • WJAHR JANUARY ISSUE PUBLISHED

    JANUARY 2021 Issue has been successfully launched on 1 January 2021.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE PROGNOSTIC VALUE OF PERIPHERAL BLOOD ABSOLUTE LYMPHOCYTE TO MONOCYTE RATIO AT DIAGNOSIS IN HODGKIN’S LYMPHOMA PATIENTS

Oula Yousef Nfelah*, Tagrid Kaddar and Firas Hussein

ABSTRACT

Determination of prognostic factors in Hodgkin’s Lymphoma patients plays an important role in reducing intensive chemotherapy, decreasing economic costs, and improving the outcome of the patients. We conducted this study to determine the prognostic value of [lymphocyte/monocyte ratio (LMR)] in Classical Hodgkin’s Lymphoma patients (cHL) [trying to establish a relationship between it, overall survival (OS) & progression free survival (PFS)]. Also, we wanted to study the relationship between LMR and other variables such as age, sex, histological type, white blood cells, absolute lymphocyte count, absolute monocyte count, hemoglobin, serum albumin, Ann Arbor Staging, B-Syptoms, early or advanced stages, bulky mediastinal mass, type of primary treatment if chemotherapy alone or radiochemotherapy and the effect of these variables on OS and PFS. A retrospective study included 242 patients with cHL admitted to the center of radiochemotherapy in Tishreen University Hospital in Lattakia from January 2011 to December 2015. We monitored the patients until 1st September 2020. An LMR at diagnosis of 2.9 or more was the best cut-off value for survival. In univariate analysis, patients with LMR < 2.9 had inferior OS and PFS. LMR had an important prognostic value in patients with limited or advanced stages. In multivariate analysis, LMR was an independent prognostic factor for survival and to predict clinical outcomes in patients with classical Hodgkin’s lymphoma. In conclusion, LMR provides a simple model to assess clinical outcomes in cHL.

[Full Text Article]